The role of hepatobiliary scintigraphy in cystic fibrosis

Hepatology

Volumn 23, Issue 2, 1996, Pages 281-287

  O'Connor, Phil J ^a   Southern, Kevin W ^a   Bowler, Ian M ^a   Irving, Henry C ^a   Robinson, Phil J ^a   Littlewood, James M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; BUTILFENIN; CHLORIDE; DISOFENIN TC 99M; TAURINE; TRACER; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ECHOGRAPHY; FEMALE; HEPATOBILIARY SCINTISCANNING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER DISEASE; LIVER FUNCTION TEST; LIVER NODULE; MALE; PRIORITY JOURNAL; STEATOSIS; SWEAT TEST;

EID: 0030066352     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008591853     Document Type: Article

References (23)

1. Dodge JA, Morison S, Lewis PA, Colest EC, Geddes D, Russell G, Bentley B. Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival. Paediatr Perinat Epidemiol 1993;7:157-166.
2. Andersen DH. Cystic fibrosis of the pancreas. Am J Dis Child 1938;56:344-399.
3. Roy CC, Weber AM, Morin CL, Lepage G, Brisson G, Yousef I, Lasalle R. Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts. J Pediatr Gastroenterol Nutr 1982;1:469-478.
4. Vawter GF, Shwachman H. Cystic fibrosis in adults: an autopsy study. Pathol Annu 1979;14:357-382.
5. Oppenheimer EH, Esterly JR. Hepatic changes in young infants with CF: possible relationship to focal biliary cirrhosis. J Pediatr 1975;86:683-689.
6. Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child 1991;66:698-701.
7. Colombo C, Setchell KD, Podda M, Crosignani A, Roda A, Curcio L, Ronchi M, et al. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr 1990;117:482-489.
8. Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, Zimmer-Nechemias L, et al. Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. HEPATOLOGY 1992;16:924-930.
9. Getting J, Lentze MJ, Reichen J. Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut 1990;31:918-921.
10. Gaskin KJ, Waters DL, Howman-Giles R, de Silva M, Earl JW, Martin HC, Kan AE, et al. Liver disease and common-bile-duct stenosis in cystic fibrosis. N Engl J Med 1988;318:340-346.
11. O'Brien S, Keogan M, Casey M, Duffy G, McErlean D, Fitzgerald MX, Hegarty JE. Biliary complications of cystic fibrosis. Gut 1992;33:387-391.
12. Nagel RA, Westaby D, Javaid A, Kavani J, Meire HB, Lombard MG, Wise A, et al. Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet 1989;2:1422-1425.
13. Dogan AS, Conway JJ, Lloyd-Still JD. Hepatobiliary scintigraphy in children with cystic fibrosis and liver disease. J Nucl Med 1994;35:432-435.
14. Colombo C, Castellani MR, Balistreri WF, Seregni E, Assaisso ML, Giunta A. Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. HEPATOLOGY 1992;15:677-684.
15. Clayton BE, Jenkins P, Round JM. Paediatric chemical pathology: clinical tests and reference ranges. London, England: Blackwell, 1980:27-28.
16. Shwachman H, Kulczycki LL. Long term study of one hundred and five patients with cystic fibrosis. AMA J Dis Child 1958;96:6-15.
17. Wilson-Sharp RC, Irving HC, Brown RC, Chalmers DM, Littlewood JM. Ultrasonography of the pancreas, liver and biliary system in cystic fibrosis. Arch Dis Child 1984;59:923-926.
18. Hubbard VS, Head GL, Shawker TH. Radiological and ultrasound evaluation of the gallbladder in patients with cystic fibrosis. Pediatr Res 1978;12:437.
19. Alder Hey book of children's doses. 6th ed. Liverpool, England: Royal Liverpool Children's NHS Trust, p. 6.
20. Brown PB, Juni JE, Lieberman DA, Krishnamurthy GT. Hepatocyte vs. biliary disease: a distinction by deconstitution analysis of Tc99m IDA time-activity curves. J Nucl Med 1988;29:623-630.
21. Newman P, Browne MK, Mowat W. A simple technique for quantitative cholescystokinin-HIDA scanning. Br J Radiol 1983;56:500-501.
22. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Lok S, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science 1989;245:1066-1073.
23. Anderson MP, Gregory RJ, Thompson S, Souza DW, Paul S, Mulligan RC, Welsh MJ. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 1991;253:202-205.